UAE Neurovascular Devices Market Size & Outlook, 2023-2030

The neurovascular devices market in the UAE is expected to reach a projected revenue of US$ 38.9 million by 2030. A compound annual growth rate of 4.9% is expected of the UAE neurovascular devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$27.8
Forecast, 2030 (US$M)
$38.9
CAGR, 2024 - 2030
4.9%
Report Coverage
UAE

UAE neurovascular devices market highlights

  • The UAE neurovascular devices market generated a revenue of USD 27.8 million in 2023 and is expected to reach USD 38.9 million by 2030.
  • The UAE market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
  • In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
  • Support Devices is the most lucrative device segment registering the fastest growth during the forecast period.


Neurovascular devices market data book summary

Market revenue in 2023USD 27.8 million
Market revenue in 2030USD 38.9 million
Growth rate4.9% (CAGR from 2023 to 2030)
Largest segmentCerebral embolization and aneurysm coiling devices
Fastest growing segmentSupport Devices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices
Key market players worldwideMedtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp


Other key industry trends

  • In terms of revenue, UAE accounted for 0.9% of the global neurovascular devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa neurovascular devices market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 45.4 million by 2030.

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 35.25% in 2023. Horizon Databook has segmented the UAE neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.


The UAE neurovascular devices market is expected to witness moderate growth rate over the forecast period. Increasing incidence of acute ischemic stroke in the UAE is a major factor contributing to the market growth. 

According to a study published by Omnia Health in 2020, in the UAE, around 7,000 stroke admissions are recorded every year and 85.00% of the stroke cases are acute ischemic strokes. Such factors are expected to positively impact the market growth.

However, low adoption rate of technologically advanced products and lack of skilled professionals in the country may hinder the market growth over the forecast period. The UAE is facing a shortage of medical personnel. 

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurovascular Devices Market Companies

Name Profile # Employees HQ Website

UAE neurovascular devices market size, by device, 2018-2030 (US$M)

UAE Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)

UAE neurovascular devices market size, by device, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more